Richard L. Schilsky, MD

Articles by Richard L. Schilsky, MD

Dr. Schilsky on the Impact of Sequestration on the FDA

ByRichard L. Schilsky, MD

June 27th 2013

Richard L. Schilsky, MD, from the University of Chicago Comprehensive Cancer Center, discusses sequestration and the effect on the FDA.

Dr. Schilsky Summarizes the Oncology Drug Shortage

ByRichard L. Schilsky, MD

June 21st 2012

Dr. Richard Schilsky, from the University of Chicago, Summarizes the Recent Oncology Drug Shortage.

Latest Updated Articles

Dr. Schilsky Summarizes the Oncology Drug Shortage
June 21st 2012
Dr. Schilsky on the Impact of Sequestration on the FDA
June 27th 2013

Trending on OncLive

FDA Approves Lirafugratinib for Pretreated, Locally Advanced or Metastatic Cholangiocarcinoma

IDMC Recommends Continuation of Phase 2 MRD Study of IMNN-001 in Advanced Ovarian Cancer

Dr Mayer on the FDA Approval of Camizestrant for ESR1-Mutated Breast Cancer

INCB161734 Holds Potential Significance for KRAS G12D–Mutated mPDAC Management

ADAM Trial Delivers Key Prospective Randomized Data for Adjuvant Avelumab in High-Risk Merkel Cell Carcinoma